Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal Cancer [Phase 3]
A Phase 3 randomized trial compares QL1706 plus bevacizumab and XELOX versus placebo plus bevacizumab and XELOX as first-line treatment for …
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Colorectal Cancers :A Retrospective Study
The record describes a Sohag University–sponsored retrospective study on colorectal cancer. The trial is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Early Detection of Advanced Adenomas and Colorectal Cancer
A City of Hope Medical Center-sponsored trial is currently recruiting to evaluate early detection methods for advanced colorectal adenomas a…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Colonoscopy and FIT as Colorectal Cancer Screening Test in the Average Risk Population [NA]
Trial investigating colonoscopy and fecal immunochemical testing (FIT) for colorectal cancer screening in average-risk individuals; sponsore…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: A Study of CDX-585 in Patients With Advanced Malignancies [Phase 1]
Phase 1 trial update showing completed enrollment and results for CDX-585 in patients with advanced solid tumors, including non-small cell l…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: AK112 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI as Second-line Treatment of MSS/pMMR Metastatic Colorectal Cancer [Phase 2]
A Phase 2 trial compares AK112 (ivonescimab) plus FOLFIRI to bevacizumab plus FOLFIRI as second-line therapy for MSS/pMMR metastatic colorec…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Atezolizumab in Patients With MSI-h/MMR-D Stage II High Risk and Stage III Colorectal Cancer Ineligible for Oxaliplatin [Phase 2]
A Phase 2 trial evaluating atezolizumab for MSI-H/MMR-D stage II high-risk and stage III colorectal cancer patients ineligible for oxaliplat…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: Incomplete Follow Up After Positive FIT or Stool DNA Testing: A Multimethod Approach [NA]
This clinical trial update highlights incomplete follow-up after a positive FIT or stool DNA test in colorectal cancer screening. The study …
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Butyrophilins Role in Colon Cancer [NA]
A clinical trial investigating the role of butyrophilins in colorectal cancer is currently recruiting, sponsored by Institut Paoli-Calmettes…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Neoadjuvant Therapy （NALIRIFOX） for Locally Advanced Colon and Upper Rectal Cancer [Phase 4]
Phase 4 clinical trial update evaluating neoadjuvant therapy with NALIRIFOX (liposomal irinotecan with fluorouracil/leucovorin) for locally …
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands [Phase 1]
Phase 1 clinical trial update of LGK974, a Wnt pathway inhibitor, in malignancies dependent on Wnt ligands; the study included several cance…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: COlorectal BReath Analysis (COBRA2)
Clinical trial COBRA2 is an ongoing study evaluating a treatment approach for colorectal cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Safety and Effectiveness Evaluation of the COLO-BT as an Alternative Treatment to the Ileostomy [NA]
This document describes a clinical trial evaluating COLO-BT as an alternative to ileostomy for colorectal cancer patients undergoing colorec…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI mCRC. [Phase 2]
Phase 2 study evaluating two regimens of nivolumab plus ipilimumab in patients with deficient mismatch repair or MSI-high metastatic colorec…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: ColoCare Study - Colorectal Cancer Cohort
The ColoCare study's colorectal cancer cohort is currently recruiting, sponsored by the University of Utah.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Vitamin E Combined With Fruquintinib and Tislelizumab in Microsatellite Stabilized Metastatic Colorectal Cancer Patients [Phase 2]
A Phase 2 clinical trial is evaluating Vitamin E combined with fruquintinib and tislelizumab in microsatellite-stable metastatic colorectal …
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health [NA]
This clinical trial update from the University of Alabama at Birmingham describes a study evaluating multiple behavior interventions to impr…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: A Study of DCTY1102 Injection in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study of DCTY1102 Injection in patients with advanced solid tumors, including pancreatic ductal adenocarcinoma, colorectal cancer, n…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
A recruiting clinical trial is investigating cognitive impairment in colorectal cancer patients receiving cytotoxic chemotherapy (chemo-brai…
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Impact of Body Mass Index and Lipid Metabolism on Anti-PD-1 Immunotherapy Outcomes in Colorectal Cancer
A completed clinical trial update examining how body mass index and lipid metabolism may influence outcomes of anti-PD-1 immunotherapy in co…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours [Phase 3]
This entry describes the Add-Aspirin Phase 3 trial evaluating whether adding aspirin after primary therapy reduces recurrence and improves s…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies [NA]
Clinical trial update for 177Lu-CTR-FAPI in advanced metastatic digestive cancers; the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Study of NKTR 255 in Combination With Cetuximab in Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study evaluating NKTR-255 in combination with cetuximab in solid tumors, including head and neck squamous cell carcinoma and color…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: HTL0039732 in Participants With Advanced Solid Tumours [Phase 1, Phase 2]
HTL0039732 is being evaluated in a Phase 1/2 study for multiple advanced solid tumours and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: QL1706 Plus Bevacizumab for Unresectable or Metastatic MSI-H/dMMR CRC [Phase 2]
A Phase 2 clinical trial is evaluating QL1706 in combination with bevacizumab for unresectable or metastatic MSI-H/dMMR colorectal cancer, w…